Neuphoria Therapeutics Inc. Gains Losses On Exchange Differences On Translation Net Of Tax
Neuphoria Therapeutics Inc. (NEUP) reported Gains Losses On Exchange Differences On Translation Net Of Tax of AUD 460.51 thousand for the 12-month period ending 2023-06-30, per its 20-F filed 2023-10-18.
Discontinued › Income Statement › Other Income
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax · last filed 2023-10-18
| Period end | Gains Losses On Exchange Differences On Translation Net Of Tax 12 month |
|---|---|
| 2023-06-30 | 460.51K AUD 20-F · filed 2023-10-18 |
| 2022-06-30 | 1.07M AUD 20-F · filed 2023-10-18 |
| 2021-06-30 | -1.17M AUD 20-F · filed 2023-10-18 |
| 2020-06-30 | 530.91K AUD 20-F · filed 2022-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |